Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with n...
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
About this item
Full title
Author / Creator
Röllig, Christoph, Dr , Serve, Hubert, Prof , Hüttmann, Andreas, MD , Noppeney, Richard, MD , Müller-Tidow, Carsten, Prof , Krug, Utz, MD , Baldus, Claudia D, Prof , Brandts, Christian H, MD , Kunzmann, Volker, Prof , Einsele, Hermann, Prof , Krämer, Alwin, Prof , Schäfer-Eckart, Kerstin, MD , Neubauer, Andreas, Prof , Burchert, Andreas, Prof , Giagounidis, Aristoteles, MD , Krause, Stefan W, Prof , Mackensen, Andreas, Prof , Aulitzky, Walter, Prof , Herbst, Regina, MD , Hänel, Mathias, MD , Kiani, Alexander, Prof , Frickhofen, Norbert, Prof , Kullmer, Johannes, MD , Kaiser, Ulrich, Prof , Link, Hartmut, Prof , Geer, Thomas, MD , Reichle, Albert, Prof , Junghanß, Christian, Prof , Repp, Roland, Prof , Heits, Frank, MD , Dürk, Heinz, Prof , Hase, Jana , Klut, Ina-Maria, PhD , Illmer, Thomas, MD , Bornhäuser, Martin, Prof , Schaich, Markus, Prof , Parmentier, Stefani, MD , Görner, Martin, MD , Thiede, Christian, Prof , von Bonin, Malte, MD , Schetelig, Johannes, Prof , Kramer, Michael, MSc , Berdel, Wolfgang E, Prof , Ehninger, Gerhard, Prof and Study Alliance Leukaemia
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background Preclinical data and results from non-randomised trials suggest that the multikinase inhibitor sorafenib might be an effective drug for the treatment of acute myeloid leukaemia. We investigated the efficacy and tolerability of sorafenib versus placebo in addition to standard chemotherapy in patients with acute myeloid leukaemia a...
Alternative Titles
Full title
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
Authors, Artists and Contributors
Author / Creator
Serve, Hubert, Prof
Hüttmann, Andreas, MD
Noppeney, Richard, MD
Müller-Tidow, Carsten, Prof
Krug, Utz, MD
Baldus, Claudia D, Prof
Brandts, Christian H, MD
Kunzmann, Volker, Prof
Einsele, Hermann, Prof
Krämer, Alwin, Prof
Schäfer-Eckart, Kerstin, MD
Neubauer, Andreas, Prof
Burchert, Andreas, Prof
Giagounidis, Aristoteles, MD
Krause, Stefan W, Prof
Mackensen, Andreas, Prof
Aulitzky, Walter, Prof
Herbst, Regina, MD
Hänel, Mathias, MD
Kiani, Alexander, Prof
Frickhofen, Norbert, Prof
Kullmer, Johannes, MD
Kaiser, Ulrich, Prof
Link, Hartmut, Prof
Geer, Thomas, MD
Reichle, Albert, Prof
Junghanß, Christian, Prof
Repp, Roland, Prof
Heits, Frank, MD
Dürk, Heinz, Prof
Hase, Jana
Klut, Ina-Maria, PhD
Illmer, Thomas, MD
Bornhäuser, Martin, Prof
Schaich, Markus, Prof
Parmentier, Stefani, MD
Görner, Martin, MD
Thiede, Christian, Prof
von Bonin, Malte, MD
Schetelig, Johannes, Prof
Kramer, Michael, MSc
Berdel, Wolfgang E, Prof
Ehninger, Gerhard, Prof
Study Alliance Leukaemia
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_osti_scitechconnect_1780176
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_osti_scitechconnect_1780176
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(15)00362-9
